Lupin appoints new president for EMEA

Lupin appoints Mr Thierry Volle as president - Europe, Middle-East & Africa (EMEA)


Mr Thierry Volle (Photo courtesy: LinkedIn/Thierry Volle)

Pharma major Lupin has announced the appointment of Mr Thierry Volle as president of Europe, Middle-East and Africa (EMEA). At Lupin, Mr Thierry will be responsible for the company's growth and development in Europe, Russia and CIS, and Middle-East and African markets. He will be based at Lupin's European headquarters in Zug, Switzerland.

Mr Thierry joins Lupin from Vifor Pharma where he was the head of EU and International business operations. Prior to that, he was at Wyeth and worked his way through multiple roles of increasing responsibility in Europe as well as the corporate headquarters in St. Davids, PA.

Mr Thierry has extensive international experience in building and growing specialty pharmaceuticals businesses across markets specifically in EMEA, with a focus on business and market development, integration and change management and product portfolio management. He holds a Business diploma from Institut Supérieur de Gestion and a Master's degree in Computer Science from Centre d'études supérieures industrielles- Centrale, Paris and has also completed various Executive Programs at the Harvard School of Public Health, INSEAD and EPFL to name a few.

Commenting on the appointment Ms Vinita Gupta, CEO, Lupin, said, "We are delighted to have Mr Thierry join the Lupin family. His rich knowledge and experience in developing and growing businesses, specifically specialty pharmaceuticals in EMEA, will help us with our strategic expansion plans for these markets."


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email